Need extra support quickly? We are working with clients around the world right now to help them tackle new challenges from COVID-19. How can we help you? Learn More >

Back to Posts

Pharmacovigilance Blog Posts

January 7, 2021 Pharmacovigilance

Achieving Success with Regulatory Intelligence in Pharmacovigilance

Regulatory intelligence is about remaining up to date with changing regulatory requirements…

Read Blog Post
November 24, 2020 Pharmacovigilance

Meet the Expert: Victor Mattisson

ProPharma Group has launched a “Meet the Expert” series introducing you to…

Read Blog Post
October 13, 2020 Pharmacovigilance

Is Your Pharmacovigilance Team Ready for Brexit?

To avoid critical issues, now is the best time to check whether…

Read Blog Post
August 12, 2020 Pharmacovigilance

EMA Vaccine Applications for COVID-19 Explained

Breaking down the pathway for COVID-19 vaccines in Europe and how the…

Read Blog Post
May 15, 2020 Pharmacovigilance

FDA Guidance for Non-COVID-19 Related Clinical Trials During the Pandemic

What does the new guidance mean for your clinical trial? Learn more…

Read Blog Post
May 7, 2020 Pharmacovigilance

Clinical Trials in the Midst of COVID-19, Part One: European...

What does this mean for your trial, and what can you do…

Read Blog Post
April 14, 2020 Pharmacovigilance

Rapid and Responsive Implementation the Right Way: Learn How Preparedness...

If your MI team is being impacted by the effects of COVID-19,…

Read Blog Post
July 9, 2019 Pharmacovigilance

Meet the Expert: Terry Hietpas

Meet PV expert Terry Hietpas, supporting clients out of our Saint Paul,…

Read Blog Post

Your Business has Complex Challenges. ProPharma Group has Exceptional Solutions.

We partner with pharmaceutical, biotechnology, and medical device clients to tackle complex challenges. Contact us to learn how our experienced team can help ensure regulatory and development success throughout the product lifecycle.

Interested in gaining an industry edge? Let us help you stay up to date.


All fields are required.